DarioHealth (DRIO) Competitors $0.62 -0.03 (-5.00%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$0.65 +0.03 (+4.17%) As of 03/28/2025 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DRIO vs. ZJYL, MGRM, LUCD, FONR, ZYXI, NSPR, EDAP, SRTS, MLSS, and NTRBShould you be buying DarioHealth stock or one of its competitors? The main competitors of DarioHealth include Jin Medical International (ZJYL), Monogram Orthopaedics (MGRM), Lucid Diagnostics (LUCD), FONAR (FONR), Zynex (ZYXI), InspireMD (NSPR), Edap Tms (EDAP), Sensus Healthcare (SRTS), Milestone Scientific (MLSS), and Nutriband (NTRB). These companies are all part of the "medical equipment" industry. DarioHealth vs. Jin Medical International Monogram Orthopaedics Lucid Diagnostics FONAR Zynex InspireMD Edap Tms Sensus Healthcare Milestone Scientific Nutriband Jin Medical International (NASDAQ:ZJYL) and DarioHealth (NASDAQ:DRIO) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, community ranking, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk. Does the MarketBeat Community prefer ZJYL or DRIO? DarioHealth received 239 more outperform votes than Jin Medical International when rated by MarketBeat users. CompanyUnderperformOutperformJin Medical InternationalN/AN/ADarioHealthOutperform Votes23966.95% Underperform Votes11833.05% Is ZJYL or DRIO more profitable? Jin Medical International has a net margin of 0.00% compared to DarioHealth's net margin of -205.62%. Jin Medical International's return on equity of 0.00% beat DarioHealth's return on equity.Company Net Margins Return on Equity Return on Assets Jin Medical InternationalN/A N/A N/A DarioHealth -205.62%-72.16%-40.74% Which has better earnings and valuation, ZJYL or DRIO? Jin Medical International has higher earnings, but lower revenue than DarioHealth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJin Medical International$23.50M4.68$3.68MN/AN/ADarioHealth$27.04M0.96-$59.43M-$0.62-1.00 Which has more volatility and risk, ZJYL or DRIO? Jin Medical International has a beta of 13.75, suggesting that its share price is 1,275% more volatile than the S&P 500. Comparatively, DarioHealth has a beta of 1.42, suggesting that its share price is 42% more volatile than the S&P 500. Do insiders and institutionals have more ownership in ZJYL or DRIO? 33.4% of DarioHealth shares are held by institutional investors. 10.9% of DarioHealth shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media favor ZJYL or DRIO? In the previous week, DarioHealth had 1 more articles in the media than Jin Medical International. MarketBeat recorded 2 mentions for DarioHealth and 1 mentions for Jin Medical International. DarioHealth's average media sentiment score of 1.45 beat Jin Medical International's score of 0.63 indicating that DarioHealth is being referred to more favorably in the news media. Company Overall Sentiment Jin Medical International Positive DarioHealth Positive Do analysts prefer ZJYL or DRIO? DarioHealth has a consensus price target of $1.50, suggesting a potential upside of 140.77%. Given DarioHealth's stronger consensus rating and higher possible upside, analysts plainly believe DarioHealth is more favorable than Jin Medical International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00DarioHealth 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryDarioHealth beats Jin Medical International on 9 of the 15 factors compared between the two stocks. Remove Ads Get DarioHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for DRIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DRIO vs. The Competition Export to ExcelMetricDarioHealthSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$25.90M$4.35B$5.63B$7.83BDividend YieldN/A32.64%4.57%4.01%P/E Ratio-0.6628.4223.3318.67Price / Sales0.9649.43388.3491.01Price / CashN/A51.0838.1634.64Price / Book0.296.046.894.23Net Income-$59.43M$67.64M$3.20B$247.15M7 Day Performance-9.46%-5.01%-2.98%-2.17%1 Month Performance-10.48%-3.28%1.63%-5.68%1 Year Performance-59.28%10.64%9.44%-0.74% DarioHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DRIODarioHealth2.755 of 5 stars$0.62-5.0%$1.50+140.8%-59.3%$25.90M$27.04M-0.66200ZJYLJin Medical InternationalN/A$0.72+10.1%N/A-81.7%$113.40M$23.50M0.00245MGRMMonogram Orthopaedics2.8689 of 5 stars$2.84-10.7%$5.40+90.1%+14.3%$100.22M$364,999.00-6.0428LUCDLucid Diagnostics3.0494 of 5 stars$1.50-1.3%$3.75+150.0%+95.1%$89.01M$4.19M-1.3270Analyst ForecastShort Interest ↓Gap UpHigh Trading VolumeFONRFONAR1.2516 of 5 stars$13.72-0.9%N/A-34.9%$85.11M$101.57M11.93480Short Interest ↑News CoveragePositive NewsZYXIZynex3.6518 of 5 stars$2.59+5.7%$10.25+295.8%-81.8%$82.65M$192.35M17.271,100Short Interest ↓News CoverageHigh Trading VolumeNSPRInspireMD2.4529 of 5 stars$2.74flat$4.75+73.4%+13.9%$81.35M$7.01M-3.6550Analyst ForecastEDAPEdap Tms2.9495 of 5 stars$2.17-0.9%$19.00+775.6%-70.7%$80.52M$63.41M-3.34230Earnings ReportAnalyst ForecastShort Interest ↓News CoverageSRTSSensus Healthcare2.1835 of 5 stars$4.81+2.1%$13.00+170.3%+25.5%$79.34M$41.81M12.0340MLSSMilestone Scientific1.7154 of 5 stars$1.01flat$1.25+23.8%+58.9%$78.67M$8.88M-14.4330Gap UpNTRBNutriband3.2721 of 5 stars$6.83+1.5%$13.00+90.3%+38.5%$75.85M$2.02M-9.6210Short Interest ↓Positive News Remove Ads Related Companies and Tools Related Companies ZJYL Alternatives MGRM Alternatives LUCD Alternatives FONR Alternatives ZYXI Alternatives NSPR Alternatives EDAP Alternatives SRTS Alternatives MLSS Alternatives NTRB Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DRIO) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DarioHealth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share DarioHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DRIO Stock Free DRIO Stock Alerts